This scumbag "journalist" is working on behalf of
Post# of 148282
Nader and everyone at CytoDyn know what they have. He's shown over and over, way beyond what any run of the mill biotech CEO would, how pro-shareholder and anti-dilution he is. Nothing could be more threatening to these adversaries.
They aren't hard to spot: just look for the people crying about PRs and short attacks, and saying we need to get rid of Nader and install a CEO friendlier to investment banks, private equity, big pharmas and cheap buyouts, dilution, and debt secured by the IP.
They won't stop until they achieve their goal, and they need the ignorant and naive to do that.
Quote:
Taking a break from the COVID discussion for a minute, I have been periodically checking in on #hollystrial GoFundMe page to see how she is doing. (https://www.gofundme.com/f/HollysCancerDrugTrialCampaign)
Today’s (second) update was the following:
———
Hi everyone.
I am back again.
To explain my comments from earlier.....
I recieved am email from a magazine last night suggesting the below.
"What evidence is there that leronlimab has helped her?
Do you know if Holly pursued treatment with Trodelvy, for instance, which was recently approved in the U.S. for advanced TNBC?
Are you worried at all that you and Holly are being exploited by people promoting leronlimab and CytoDyn for financial reasons?
I'd like to speak with you if you have time.
Thank you --"
To be clear-
I merely set up a fund to help my friend in her chosen trial drug, to help lengthen her life.
This is Hollys trial drug of choice.
Comments and emails like the above are undermining , decisive and unhelpful.
I hope you understand that from here on in, I will not reply to emails from magazines , medical or otherwise.
I will do a video on this matter during the week .
Big love
Olive
#leronlimab continues... Week 7 of a year long trial
———
Makes me a little angry, but good for Olive for not putting up with it!!!